Federal award
BLOODWORKS
HT940622P0003
Contract
Obligated and Ceiling
- Obligated (net)
- $156,904.96
- Ceiling (potential value, not spending)
- $156,904.96
- Current value
- $156,904.96
- Gross positive obligations
- $714,986.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BLOODWORKS · ZN56PFWUDQK7
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BLOODWORKS · ZN56PFWUDQK7
- Awarding agency
- Department of War · sub-agency 97DH · office HT9410
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT940622P0003
- Award type code
- B
- Actions
- 6 · Feb 28, 2022 to Jun 25, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 25, 2025 | FY2025 | P00005 | B | −$558,081.04 | — |
| Feb 27, 2023 | FY2023 | P00004 | G | $372,235.00 | — |
| Jun 27, 2022 | FY2022 | P00003 | M | $0.00 | — |
| May 24, 2022 | FY2022 | P00002 | M | $0.00 | — |
| Apr 26, 2022 | FY2022 | P00001 | D | $0.00 | — |
| Feb 28, 2022 | FY2022 | 0 | — | $342,751.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.